Host defense system interactions with Candida

REFERENCES

• Al-Doory Y. An immune factor in baboon anti-Candida serum. Sabouraudia 1970; 8: 31–47
   Google Scholar
• Arai T., Mikami Y., Yokoyama D. Phagocytosis of Candida albicans by rabbit alveolar macrophages and guinea pig neutrophils. Sabouraudia 1977; 15: 171–178
   PubMedGoogle Scholar
• Ashman R.B. Mouse candidiasis. II. Host responses are T cell dependent and regulated by genes in the major histocompatibility complex. Immunogenetics 1987; 25: 200–203
   PubMed Web of Science ®Google Scholar
• Ashman R.B., Papadimitriou J.M. Susceptibility of beige mutant mice to candidiasis may be linked to a defect in granulocyte production by bone marrow stem cells. Infection and Immunity 1991; 59: 2140–2146
   PubMed Web of Science ®Google Scholar
• Baghian A., Lee K.W. Role of activated macrophages in resistance to systemic candidosis. Journal of Leukocyte Biology 1988; 44: 166–171
   PubMed Web of Science ®Google Scholar
• Baghian A., Lee K.W. Systemic candidosis in beige mice. Journal of Medical and Veterinary Mycology 1989; 27: 51–55
   PubMedGoogle Scholar
• Balish E., Filutowicz H., Oberley T.D. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infection and Immunity 1990; 58: 107–113
   PubMed Web of Science ®Google Scholar
• Beno D.W.A., Mathews H.L. Growth inhibition of Candida albicans by interleukin-2-induced lymph node cells. Cellular Immunology 1990; 128: 89–100
   PubMed Web of Science ®Google Scholar
• Bistoni F., Vecchiarelli A., Cenci E., Puccetti P., Marconi P., Cassone A. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infection and Immunity 1986; 51: 668–674
   PubMed Web of Science ®Google Scholar
• Blanchard D.K., Michelini-Norris M.B., Djeu J.Y. Production of granulocyte macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: Role in activation of human neutrophil function. Blood 1991; 77: 2259–2265
   PubMed Web of Science ®Google Scholar
• Blasi E., Farinelli S., Varesio L., Bistoni F. Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1. Infection and Immunity 1990; 58: 1073–1077
   PubMed Web of Science ®Google Scholar
• Bodey G.P., Bolivar R., Fainstein V. Infectious complications in leukemic patients. Seminars in Hematology 1982; 19: 193–226
   PubMed Web of Science ®Google Scholar
• Bolivar R., Bodey G.P. Candidiasis of the gastrointestinal tract. Candidiasis, G.P. Bodey, V. Fainstein. Raven Press, New York 1985; 181–201, In
   Google Scholar
• Bosma M.J. The scid mutation: Occurrence and effect. Current Topics in Microbiology and Immunology 1989; 152: 3–9
   PubMed Web of Science ®Google Scholar
• Bross J., Talbot G.H., Maislin G., Hurwitz S., Strom B.L. Risk factors for nosocomial candidemia: a case-control study in adults without acute leukemia. American Journal of Medicine 1989; 87: 614–620
   PubMed Web of Science ®Google Scholar
• Brummer E., Stevens D.A. Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines. Clinical and Experimental Immunology 1987; 70: 520–528
   PubMed Web of Science ®Google Scholar
• Calderone R.A., Braun P.C. Adherence and receptor relationships of Candida albicans. Microbiological Reviews 1991; 55: 1–20
   PubMedGoogle Scholar
• Cantorna M.T., Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infection and Immunity 1990; 58: 1093–1100
   PubMed Web of Science ®Google Scholar
• Cantorna M.T., Balish E. Role of CD4+ lymphocytes in resistance to mucosal candidiasis. Infection and Immunity 1991; 59: 2447–2455
   PubMed Web of Science ®Google Scholar
• Carlson E. Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus fecalis in the establishment of infection in mice. Infection and Immunity 1983; 39: 193–197
   PubMed Web of Science ®Google Scholar
• Carlson E., Johnson G. Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice. Infection and Immunity 1985; 50: 655–659
   PubMed Web of Science ®Google Scholar
• Carrow E.W., Domer J.E. Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein. Infection and Immunity 1985; 49: 172–181
   PubMed Web of Science ®Google Scholar
• Cenci E., Bartocci A., Puccetti P., Mocci S., Stanley E.R., Bistoni F. Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration. Infection and Immunity 1991; 59: 868–872
   PubMed Web of Science ®Google Scholar
• Cenci E., Romani L., Vecchiarelli A., Puccetti P., Bistoni F. Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infection and Immunity 1989; 57: 3581–3587
   PubMed Web of Science ®Google Scholar
• Cenci E., Romani L., Vecchiarelli A., Puccetti P., Bistoni F. T cell subsets and IFN-γ production in resistance to systemic candidosis in immunized mice. Journal of Immunology 1990; 144: 4333–4339
   PubMed Web of Science ®Google Scholar
• Cheers C., Walker R. Activated macrophages in congenitally athymic ‘nude’ mice and in lethally irradiated mice. Journal of Immunology 1975; 115: 844–847
   PubMed Web of Science ®Google Scholar
• Chow H.S., Sarpel S.C., Epstein R.B. Experimental candidiasis in neutropenic dogs: tissue burden of infection and granulocyte transfusion effects. Blood 1982; 59: 328–333
   PubMed Web of Science ®Google Scholar
• Cochrane C.G., Muller-Eberhard H.J., Aikin B.S. Depletion of plasma complement in vivo by a protein of cobra venom: Its effect on various immunologic reactions. Journal of Immunology 1970; 105: 55–69
   PubMed Web of Science ®Google Scholar
• Cohen M.S., Isturiz R.E., Malech H.L., Root R.K., Wilfert C.N., Gutman L., Buckley H.R. Fungal infection in chronic granulomatous disease: the importance of the phagocyte in defense against fungi. American Journal of Medicine 1981; 71: 59–66
   PubMed Web of Science ®Google Scholar
• Cole G.T., Lynn K.T., Seshan K.R., Pope L.M. Gastrointestinal and systemic candidosis in immunocompromised mice. Journal of Medical and Veterinary Mycology 1989; 27: 363–380
   PubMedGoogle Scholar
• Cole G.T., Seshan K.R., Pope L.M., Yancey R.J. Morphological aspects of gastrointestinal tract invasion by Candida albicans in the infant mouse. Journal of Medical and Veterinary Mycology 1988; 26: 173–185
   PubMedGoogle Scholar
• Crislip M.A., Edwards J.E., Jr. Candidiasis. Infectious Disease Clinics of North America 1989; 3: 103–133
   PubMedGoogle Scholar
• Cutler J.E. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. Journal of the Reticuloendothelial Society 1976; 19: 121–124
   PubMedGoogle Scholar
• Czop J.K., Austen K.F. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor. Journal of Immunology 1985; 135: 3388–3393
   PubMed Web of Science ®Google Scholar
• Danley D.L., Polakoff J. Rapid killing of monocytes in vitro by Candida albicans yeast cells. Infection and Immunity 1986; 51: 307–313
   PubMed Web of Science ®Google Scholar
• Davies R.R., Denning T.J.V. Candida albicans and the fungicidal activity of blood. Sabouraudia 1972; 10: 301–307
   PubMedGoogle Scholar
• De Bernardis F., Agatensi L., Ross I.K., Emerson G.W., Lorenzini R., Sullivan P.A., Cassone A. Evidence for a role for secreted asparate proteinase of Candida albicans in vulvovaginal candidiasis. Journal of Infectious Diseases 1990; 161: 1276–1283
   PubMed Web of Science ®Google Scholar
• Decker T., Lohmann-Matthes M.-L., Baccarini M. Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans. Infection and Immunity 1986; 54: 477–486
   PubMed Web of Science ®Google Scholar
• Degregorio M.W., Lee W.M.F., Linker C.A., Jacobs R.A., Ries C.A. Fungal infections in patients with acute leukemia. American Journal of Medicine 1982; 73: 543–548
   PubMed Web of Science ®Google Scholar
• DeMaria A., Buckley H., von Lichtenberg F. Gastrointestinal candidiasis in rats treated with antibiotics, cortisone, and azathioprine. Infection and Immunity 1976; 13: 1761–1770
   PubMed Web of Science ®Google Scholar
• Diamond R.D., Lyman C.A., Wysong D.A. Disparate effect of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro. Journal of Clinical Investigation 1991; 87: 711–720
   PubMed Web of Science ®Google Scholar
• Djeu J.Y., Blanchard D.K. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. Journal of Immunology 1987; 139: 2761–2767
   PubMed Web of Science ®Google Scholar
• Djeu J.Y., Blanchard D.K., Halkias D., Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. Journal of Immunology 1986; 137: 2980–2984
   PubMed Web of Science ®Google Scholar
• Djeu J.Y., Blanchard D.K., Richards A.L., Friedman H. Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. Journal of Immunology 1988; 141: 4047–4052
   PubMed Web of Science ®Google Scholar
• Domer J.E. Intragastric colonization of infant mice with Candida albicans induces systemic immunity demonstrable upon challenge as adults. Journal of Infectious Diseases 1988; 157: 950–958
   PubMed Web of Science ®Google Scholar
• Domer J.E., Carrow E.W. Candidiasis. Immunology of the Fungal Diseases, R.A. Cox. CRC Press, Boca Raton, FL 1989; 57–92, In
   Google Scholar
• Domer J.E., Moser S.A. Experimental murine candidiasis: Cell-mediated immunity after cutaneous challenge. Infection and Immunity 1978; 20: 88–97
   PubMed Web of Science ®Google Scholar
• Dreizen S. Oral candidiasis. American Journal of Medicine 1984; 77: 28–33
   PubMed Web of Science ®Google Scholar
• Durum S.K., Oppenheim J.J. Macrophage-derived mediators: Interleukin 1, tumor necrosis factor, interleukin 6, interferon, and related cytokines. Fundamental Immunology, W.E. Paul. Raven Press, New York 1989; 639–661, In
   Google Scholar
• Edwards J.E., Jr. Candidemia and Candida catheter-associated sepsis. Diagnosis and Therapy of Systemic Fungal Infections, K. Holmberg, R.D. Meyer. Raven Press, New York 1989; 39–46, In
   Google Scholar
• Ekenna O., Sheretz R.J. Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice. Infection and Immunity 1987; 55: 1558–1563
   PubMed Web of Science ®Google Scholar
• Elin R.J., Edelin J.B., Wolff S.M. Infection and immunoglobulin concentrations in Chediak-Higashi mice. Infection and Immunity 1974; 10: 88–91
   PubMed Web of Science ®Google Scholar
• Faix R.G., Kovarik S.M., Shaw T.R., Johnson R.V. Mucocutaneous and invasive candidiasis among very low birth weight (less than 1500 grams) infants in intensive care nurseries: a prospective study. Pediatrics 1989; 83: 101–107
   PubMed Web of Science ®Google Scholar
• Fauci A.S. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Annals of Internal Medicine 1991; 114: 678–693
   PubMed Web of Science ®Google Scholar
• Ferrante A. Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: Increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infection and Immunity 1989; 57: 2115–2122
   PubMed Web of Science ®Google Scholar
• Ferrari F.A., Pagani A., Marconi M., Stefanoni R., Siccardi A.G. Inhibition of candidacidal activity of human neutrophil leukocytes by aminoglycoside antibiotics. Antimicrobial Agents and Chemotherapy 1980; 17: 87–88
   PubMed Web of Science ®Google Scholar
• Field L.H., Pope L.M., Cole G.T., Guentzel M.N., Berry L.J. Persistence and spread of Candida albicans after intragastric inoculation of infant mice. Infection and Immunity 1981; 31: 783–791
   PubMed Web of Science ®Google Scholar
• Fine D.P. Complement and Infectious Diseases. CRC Press, Boca Raton, FL 1981
   Google Scholar
• Forsgren A., Schmeling D., Quie P.G. Effect of tetracycline on the phagocytic function of human leukocytes. Journal of Infectious Diseases 1974; 130: 412–415
   PubMed Web of Science ®Google Scholar
• Fraser-Smith E.B., Epstein D.A., Larsen M.A., Matthews T.R. Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infections. Infection and Immunity 1983; 39: 172–178
   PubMed Web of Science ®Google Scholar
• Fromtling R.A., Shadomy H.J. An overview of macrophage-fungal interactions. Mycopathologia 1986; 93: 77–93
   PubMed Web of Science ®Google Scholar
• Garner R.E., Kuruganti U., Czarniecki C.W., Chiu H.H., Domer J.E. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Infection and Immunity 1989; 57: 1800–1808
   PubMed Web of Science ®Google Scholar
• Gelfand J.A., Hurley D.L., Fauci A.S., Frank M.M. Role of complement in host defense against experimental disseminated candidiasis. Journal of Infectious Diseases 1978; 138: 9–16
   PubMed Web of Science ®Google Scholar
• Ghannoum M., Elteen K.A. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. Journal of Medical and Veterinary Mycology 1986; 24: 407–413
   PubMedGoogle Scholar
• Giger D.K., Domer J.E., Moser S.A., McQuitty T.J., Jr. Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice. Infection and Immunity 1978; 21: 729–737
   PubMed Web of Science ®Google Scholar
• Goldblum S.E., Reed W.P. Host defenses and immunological alterations associated with chronic hemodialysis. Annals of Internal Medicine 1980; 93: 597–613
   PubMed Web of Science ®Google Scholar
• Greenfield R.A., Stephens J.L., Bussey M.J., Jones J.M. Quantitation of antibody to Candida mannan by enzyme-linked immunosorbent assay. Journal of Laboratory and Clinical Medicine 1983; 101: 758–771
   PubMed Web of Science ®Google Scholar
• Greenfield R.A., Troutt D.L., Rickard R.C., Altmiller D.H. Comparison of antibody, antigen, and metabolite assays in rat models of systemic and gastrointestinal candidiasis. Journal of Clinical Microbiology 1988; 26: 409–417
   PubMed Web of Science ®Google Scholar
• Guentzel M.N., Herrerra C. Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy. Infection and Immunity 1982; 35: 222–228
   PubMed Web of Science ®Google Scholar
• Haskell C.M. Principles and practice of cancer chemotherapy. Cancer Treatment, C.M. Haskell. W. B. Saunders Company, Philadelphia, PA 1990; 21–43, In
   Google Scholar
• Hector R.F., Domer J.E., Carrow E.W. Immune responses to Candida albicans in genetically distinct mice. Infection and Immunity 1982; 38: 1020–1028
   PubMed Web of Science ®Google Scholar
• Helstrom P.B., Balish E. Effect of oral tetracyline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans. Infection and Immunity 1979; 23: 764–774
   PubMed Web of Science ®Google Scholar
• Horan T., Culver D., Jarvis W., Emori G., Banerjee S., Martone W., Thornsberry C. Pathogens causing nosocomial infections. Preliminary data from the National Nosocomial Infection Surveillance System. Antimicrobial Newsletter 1988; 5: 65–67
   Google Scholar
• Howlett J.A., Squier C.A. Candida albicans ultrastructure: colonization and invasion of oral epithelium. Infection and Immunity 1980; 29: 252–260
   PubMed Web of Science ®Google Scholar
• Hurtrel B., Lagrange P.H., Michel J.C. Absence of correlation between delayed-type hypersensitivity and protection in experimental candidiasis in immunized mice. Infection and Immunity 1981; 31: 95–101
   PubMed Web of Science ®Google Scholar
• Imam N., Carpenter C.C.J., Mayer K.H., Fisher A., Stein M., Danforth S.B. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. American Journal of Medicine 1990; 89: 142–146
   PubMed Web of Science ®Google Scholar
• Janusz M.J., Austen K.F., Czop J.K. Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte β-glucan receptors. Immunology 1988; 65: 181–186
   PubMed Web of Science ®Google Scholar
• Kagaya K., Fukazawa Y. Murine defense mechanisms against Candida albicans infection. II. Opsonization, phagocytosis, and intracellular killing of C. albicans. Microbiology and Immunology 1981; 25: 807–818
   PubMed Web of Science ®Google Scholar
• Kashima M., Takahashi H., Shimozuma M., Epstein W.L., Fukuyama K. Candidacidal activities of proteins partially purified from rat epidermis. Infection and Immunity 1989; 57: 186–190
   PubMed Web of Science ®Google Scholar
• Kennedy M.J. Inhibition of Candida albicans by the anaerobic oral flora of mice in vitro. Sabouraudia 1981; 19: 205–208
   PubMedGoogle Scholar
• Kennedy M.J., Rogers A.L., Hanselman L.R., Soll D.R., Yancey R.J., Jr. Variation in adhesion and cell surface hydrophobicity in Candida albicans white and opaque phenotypes. Mycopathologia 1988; 102: 149–156
   PubMed Web of Science ®Google Scholar
• Kennedy M.J., Volz P.A. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infection and Immunity 1985; 49: 654–663
   PubMed Web of Science ®Google Scholar
• Kim O., Rodey G.E., Good R.A., Chilgren R.A., Quie P.G. Defective candidacidal capacity of polymorphonuclear leukocytes in chronic granulomatous disease of childhood. Journal of Pediatrics 1969; 75: 300–303
   PubMed Web of Science ®Google Scholar
• Kirkpatrick C.H. Chronic mucocutaneous candidiasis. European Journal of Clinical Microbiology and Infectious Diseases 1989; 8: 448–456
   PubMed Web of Science ®Google Scholar
• Kletter Y., Bleiberg I., Golde D.W., Fabian I. Antibody to Mo1 abrogates the increase in neutrophil phagocytosis and degranulation induced by granulocyte-macrophage colony-stimulating factor. European Journal of Haematology 1989; 43: 389–396
   PubMed Web of Science ®Google Scholar
• Kochhar R., Singh S., Talwar P., Mehta S.K. Candidiasis after cimetadine therapy. Gastrointestinal Endoscopy 1988; 34: 283–284
   PubMed Web of Science ®Google Scholar
• Kolotila M.P., Diamond R.D. Stimulation of neutrophil actin polymerization and degranulation by opsonized and unopsonized Candida albicans and zymosan. Infection and Immunity 1988; 56: 2016–2022
   PubMed Web of Science ®Google Scholar
• Kolotila M.P., Diamond R.D. Effects of neutrophils and in vitro oxidants on survival and phenotypic switching of Candida albicans WO-1. Infection and Immunity 1990; 58: 1174–1179
   PubMed Web of Science ®Google Scholar
• Kozel T.R., Brown R.R., Pfrommer G.S. Activation and binding of C3 by Candida albicans. Infection and Immunity 1987; 55: 1890–1894
   PubMed Web of Science ®Google Scholar
• Krause W., Matheis H., Wulf K. Fungaemia and funguria after oral administration of Candida albicans. Lancet 1969; i: 598–599
   Google Scholar
• Kullberg B.-J., Van't Wout J.W., Van Furth R. Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1. Infection and Immunity 1990; 58: 3319–3324
   PubMed Web of Science ®Google Scholar
• Kwon-Chung K.J., Lehmann D., Good C., Magee P.T. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infection and Immunity 1985; 49: 571–575
   PubMed Web of Science ®Google Scholar
• Lee K.W., Balish E. Systemic candidosis in germfree, flora-defined and conventional nude and thymus-bearing mice. Journal of the Reticuloendothelial Society 1981; 29: 71–77
   PubMedGoogle Scholar
• Lee K.W., Balish E. Systemic candidosis in silica-treated athymic and euthymic mice. Infection and Immunity 1983; 41: 902–907
   PubMed Web of Science ®Google Scholar
• Lehrer R.I. Inhibition by sulfonamides of the candidacidal activity of human neutrophils. Journal of Clinical Investigation 1971; 50: 2498–2505
   PubMed Web of Science ®Google Scholar
• Lehrer R.I., Cline M.J. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. Journal of Clinical Investigation 1969; 48: 1478–1488
   PubMed Web of Science ®Google Scholar
• Levy M.H., Wheelock E.F. Effects of intravenous silica on immune and non-immune functions of the murine host. Journal of Immunology 1975; 115: 41–48
   PubMed Web of Science ®Google Scholar
• Louria D.B., Brayton R.G. Behavior of Candida cells within leukocytes. Proceedings of the Society of Experimental Biology and Medicine 1964; 115: 93–98
   PubMed Web of Science ®Google Scholar
• Louria D.B., Smith J.K., Brayton R.G., Buse M. Anti-Candida factors in serum and their inhibitors. I. Clinical and laboratory observations. Journal of Infectious Diseases 1972; 125: 102–114
   PubMed Web of Science ®Google Scholar
• Lyman C.A., Simons E.R., Melnick D.A., Diamond R.D. Induction of signal transduction in human neutrophils by Candida albicans hyphae: the role of pertussis toxin-sensitive guanosine triphosphate-binding proteins. Journal of Infectious Diseases 1988; 158: 1056–1064
   PubMed Web of Science ®Google Scholar
• Lyon F.L., Hector R.F., Domer J.E. Innate and acquired immune responses against Candida albicans in congenic B10.D2 mice with deficiency of the C5 complement component. Journal of Medical and Veterinary Mycology 1986; 24: 359–367
   PubMedGoogle Scholar
• Mahanty S., Greenfield R.A., Joyce W.A., Kincade P.W. Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome. Infection and Immunity 1988; 56: 3162–3166
   PubMed Web of Science ®Google Scholar
• Maki D.G. Pathogenesis, prevention, and management of infections due to intravascular devices used for infusion therapy. Infections Associated with Indwelling Medical Devices, A.L. Bisno, F.A. Waldvogel. American Society for Microbiology, Washington, D.C. 1989; 161–178, In
   Google Scholar
• Makysmiuk A.W., Thongprasert S., Hopeer T., Luna M., Fainstein V., Bodey G.P. Systemic candidiasis in cancer patients. American Journal of Medicine 1984; 77: 20–27
   PubMed Web of Science ®Google Scholar
• Mannion B.A., Weiss J., Elsbach P. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli. Journal of Clinical Investigation 1990; 86: 631–641
   PubMed Web of Science ®Google Scholar
• Marconi P., Saringi L., Tissi L., Boccanera M., Bistoni F., Bonmassar E., Cassone A. Induction of natural killer cell activity by inactivated Candida albicans in mice. Infection and Immunity 1985; 50: 297–303
   PubMed Web of Science ®Google Scholar
• Matthews R., Smith D., Midgley J., Burnie J., Clark I., Conolly M., Gazzard B. Candida and AIDS: Evidence for protective antibody. Lancet 1988; ii: 263–266
   Google Scholar
• McNamara M.P., Collins-Lech C., Wiessner J.H., Hahn B.L., Sohnle P.G. Neutrophil death as a defense mechanism against Candida albicans infections. Lancet 1988; ii: 1163–1165
   Google Scholar
• Melbye M., Schonheyder H., Kestens L., Stenderup A., Gigase P.L., Ebbesen P., Biggar R.J. Carriage of oral Candida albicans associated with a high number of circulating suppressor lymphocytes. Journal of Infectious Diseases 1985; 152: 1356–1356
   PubMed Web of Science ®Google Scholar
• Meyer R.D., Holmberg K. Fungal infections in HIV-infected patients. Diagnosis and Therapy of Systemic Fungal Infections, K. Holmberg, R.D. Meyer. Raven Press, New York 1989; 79–100, In
   Google Scholar
• Minami A., Fujimoto K., Ozaki Y., Nakamura S. Augmentation of host resistance to microbial infection by recombinant human interleukin-1-alpha. Infection and Immunity 1988; 56: 3116–3120
   PubMed Web of Science ®Google Scholar
• Miyake T.K., Takeya K., Nomoto K., Muraoka J. Cellular elements in the resistance to Candida infection in mice. I. Contribution of T lymphocytes and phagocytes at various stages of infection. Microbiology and Immunology 1977; 21: 703–725
   PubMed Web of Science ®Google Scholar
• Morelli R., Rosenburg L.T. The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes. Journal of Immunology 1971; 107: 476–480
   PubMed Web of Science ®Google Scholar
• Morelli R., Rosenburg L.T. Role of complement during experimental Candida infection in mice. Infection and Immunity 1974; 3: 521–523
   Google Scholar
• Morrison R.P., Cutler J.E. In vitro studies of the interaction of murine phagocytic cells with Candida albicans. Journal of the Reticuloendothelial Society 1981; 29: 23–34
   PubMedGoogle Scholar
• Mourad S., Friedman L. Passive immunization of mice against Candida albicans. Sabouraudia 1968; 6: 103–105
   PubMedGoogle Scholar
• Murphy J.W. Immunity to fungi. Current Opinion in Immunology 1990; 2: 360–367
   Web of Science ®Google Scholar
• Myerowitz R.L., Pazin G.J., Allen C.M. Disseminated candidiasis: Changes in incidence, underlying diseases, and pathology. American Journal of Clinical Pathology 1977; 68: 29–38
   PubMed Web of Science ®Google Scholar
• Narayanan R., Joyce W.A., Greenfield R.A. Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infection and Immunity 1991; 59: 2116–2119
   PubMed Web of Science ®Google Scholar
• Nelson R.D., Shibata N., Podzorski R.P., Herron M.J. Candida mannan: Chemistry, suppression of cell-mediated immunity, and possible mechanisms of action. Clinical Microbiology Reviews 1991; 4: 1–19
   PubMed Web of Science ®Google Scholar
• Nickol A.D., Bonventre P.F. Anomalous high native resistance of athymic mice to bacterial pathogens. Infection and Immunity 1977; 18: 636–645
   PubMed Web of Science ®Google Scholar
• Odds F.C. Candida and Candidosis. A Review and Bibliography2nd edn. Ballière Tindall, London 1988
   Google Scholar
• Ozato K., Uesaka I. The role of macrophages in Candida albicans infection in vitro. Japanese Journal of Microbiology 1974; 18: 29–35
   PubMedGoogle Scholar
• Pearsall N.N., Adams B.L., Bunni R. Immunologic responses to Candida albicans. III. Effect of passive transfer of lymphoid cells or serum on murine candidiasis. Journal of Immunology 1978; 120: 1176–1180
   PubMed Web of Science ®Google Scholar
• Pearsall N., Lagunoff D. Immunological responses to Candida albicans. I. Mouse-thigh lesion as a model for experimental candidiasis. Infection and Immunity 1974; 9: 999–1002
   PubMed Web of Science ®Google Scholar
• Pecyk R.A., Fraser-Smith E.B., Matthews T.R. Efficacy of interleukin-1-beta against systemic Candida albicans infection in normal and immunosuppressed mice. Infection and Immunity 1989; 57: 3257–3258
   PubMed Web of Science ®Google Scholar
• Ray T.L., Hanson A., Ray L.F., Wuepper K.D. Purification of a mannan from candida albicans which activates serum complement. Journal of Investigative Dermatology 1979; 73: 269–274
   PubMed Web of Science ®Google Scholar
• Ray T.L., Payne C.D. Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: A role of Candida acid proteinase. Infection and Immunity 1988; 56: 1942–1949
   PubMed Web of Science ®Google Scholar
• Rhpi L., Carlson E. Tumor necrosis factor (TNF) is induced in mice by Candida albicans: role of TNF in fibrinogen increase. Infection and Immunity 1990; 58: 2750–2754
   PubMed Web of Science ®Google Scholar
• Rivas R., Rogers T.J. Studies on the cellular nature of Candida albicans-induced suppression. Journal of Immunology 1983; 130: 376–379
   PubMed Web of Science ®Google Scholar
• Rogers T.J., Balish E. The role of activated macrophages in resistance to experimental renal candidiasis. Journal of the Reticuloendothelial Society 1977; 22: 309–318
   PubMedGoogle Scholar
• Rogers T., Balish E. Immunity to experimental renal candidiasis in rats. Infection and Immunity 1978; 19: 737–740
   PubMed Web of Science ®Google Scholar
• Rogers T.J., Balish E. Immunity of Candida albicans. Microbiological Reviews 1980; 44: 660–682
   PubMedGoogle Scholar
• Rogers T.J., Balish E., Manning D.D. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. Journal of the Reticuloendothelial Society 1976; 20: 291–298
   PubMedGoogle Scholar
• Roilides E., Walsh T.J., Pizzo P.A., Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. Journal of Infectious Diseases 1991; 163: 579–583
   PubMed Web of Science ®Google Scholar
• Ruiz P., Gomez F., Schreiber A.D. Impaired function of macrophage FCγ receptors in endstage renal disease. New England Journal of Medicine 1990; 322: 717–722
   PubMed Web of Science ®Google Scholar
• Sandovsky-Losica H., Segal E. Interaction of Candida albicans with murine gastrointestinal mucosa from methotrexate and 5-fluorouracil treated animals: in vitro adhesion and prevention. Journal of Medical and Veterinary Mycology 1990; 28: 279–287
   PubMed Web of Science ®Google Scholar
• Scaringi L., Cornacchione P., Rosati E., Boccanera M., Cassone A., Bistoni F., Marconi P. Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans. Cellular Immunology 1990; 129: 271–287
   PubMed Web of Science ®Google Scholar
• Scaringi L., Marconi P., Boccanera M., Tissi L., Bistoni F., Cassone A. Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. Journal of General Microbiology 1988; 134: 1265–1274
   PubMedGoogle Scholar
• Schonheyder H., Melbye M., Biggar R.J., Ebbesen P., Neuland C.Y., Stenderup A. Oral yeast flora and antibodies to Candida albicans in homosexual men. Mykosen 1984; 27: 539–544
   PubMedGoogle Scholar
• Segal E., Sandovsky-Losica H., Vardinon N. Suppressive action of cytoplasmic and metabolic extracts of Candida albicans on the immune response in guinea pigs. Mycopathologia 1980; 72: 121–128
   PubMed Web of Science ®Google Scholar
• Shiotsuki K., Wang M., Blanchard D.K., Djeu J.Y. Activation of human polymorphonuclear-mediated anti-Candida activity by recombinant interleukin 3: comparison with GM-CSF and G-CSF. Abstracts of the Annual Meeting of the American Society for Microbiology. Washington, D.C. 1989; 470–470, In
   Google Scholar
• Shultz L.D., Sidman C.L. Genetically determined murine models of immunodeficiency. Annual Reviews of Immunology 1987; 5: 367–403
   PubMed Web of Science ®Google Scholar
• Sinha B.K., Prasad S., Monga D.P. Studies in experimental candidiasis in T-cell-deficient mice. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology 1987; 265: 203–209
   PubMedGoogle Scholar
• Slutsky B., Buffo J., Soll D.R. High frequency switching of colony morphology in Candida albicans. Science 1985; 230: 666–669
   PubMed Web of Science ®Google Scholar
• Smith J., Louria D. Anti-Candida factors in serum and their inhibitors. II. Identification of a Candida-clumping factor and the influence of the immune response on the morphology of Candida and on anti-Candida activity of serum in rabbits. Journal of Infectious Diseases 1972; 125: 115–122
   PubMed Web of Science ®Google Scholar
• Smith P.D., Lamerson C.L., Banks S.M., Saini S.S., Wahl L.M., Calderone R.A., Wahl S.M. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity to Candida albicans. Journal of Infectious Diseases 1990; 161: 999–1005
   PubMed Web of Science ®Google Scholar
• Sohnle P.G., Collins-Lech C. Comparison of candidacidal and candidiastatic activities of human neutrophils. Infection and Immunity 1990; 58: 2696–2698
   PubMed Web of Science ®Google Scholar
• Sohnle P.G., Frank M.M., Kirkpatrick C.H. Mechanism involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs. Journal of Immunology 1970; 117: 523–530
   Google Scholar
• Solomkin J.S., Mills E.L., Giebink G.S., Nelson R.D., Simmons R.L., Quie P. Phagocytosis of Candida albicans by human leukocytes: Opsonic requirements. Journal of Infectious Diseases 1978; 137: 30–37
   PubMed Web of Science ®Google Scholar
• Stanley V.C., Hurley R. The growth of Candida species in cultures of mouse peritoneal macrophages. Journal of Pathology 1969; 97: 357–366
   PubMed Web of Science ®Google Scholar
• Stevens D.A., Odds F.C., Scherer S. Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype. Reviews of Infectious Diseases 1990; 12: 258–266
   PubMedGoogle Scholar
• Sugar A.M., Brummer E., Stevens D.A. Murine pulmonary macrophages: evaluation of lung lavage fluids, miniaturized monolayers, and candidacidal activity. American Review of Respiratory Disease 1983; 127: 110–118
   PubMed Web of Science ®Google Scholar
• Thaler M., Pastakia B., Shawker T.H., O'Leary T., Pizzo P.A. Hepatic candidiasis in cancer patients: The evolving picture of the syndrome. Annals of Internal Medicine 1988; 108: 88–100
   PubMed Web of Science ®Google Scholar
• Thong Y.H., Ferrante A. Alternative pathway of complement activation by Candida albicans. Australia and New Zealand Journal of Medicine 1978; 8: 620–622
   PubMedGoogle Scholar
• Trier J.S., Bjorkman D.J. Esophageal, gastric, and intestinal candidiasis. American Journal of Medicine 1984; 77: 39–43
   PubMed Web of Science ®Google Scholar
• Triger D.R., Slater D.N., Goepel J.R., Underwook J.C.E. Systemic candidiasis complicating acute hepatic failure in patients treated with cimetadine. Lancet 1981; ii: 837–838
   Google Scholar
• Van't Wout J.W., Linde I., Leijh P.C.J., Van Furth R. Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. European Journal of Clinical Microbiology and Infectious Diseases 1988; 7: 736–741
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A., Bistoni F., Cenci E., Perito S., Cassone A. In vitro killing of Candida species by murine immunoeffectors and its relationship to experimental pathogenicity. Sabouraudia: Journal of Medical and Veterinary Mycology 1985; 23: 377–387
   Google Scholar
• Vecchiarelli A., Puliti M., Torosantucci A., Cassone A., Bistoni F. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cellular Immunology 1991; 134: 65–76
   PubMed Web of Science ®Google Scholar
• Volkheimer G., Schulz F.H. The phenomenon of persorption. Digestion 1968; 1: 213–218
   PubMed Web of Science ®Google Scholar
• Wang M., Friedman H., Djeu J.Y. Enhancement of human monocyte function against Candida albicans by the colony stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. Journal of Immunology 1989; 143: 671–677
   PubMed Web of Science ®Google Scholar
• Warnock D.W., Speller D.C.E., Finan P.J., Vellacott J.D., Phillips M.N. Antibodies to Candida species after operations on the large intestine. Observations on the association with oral and faecal yeast colonization. Sabouraudia 1979; 17: 405–414
   PubMedGoogle Scholar
• Watanabe K., Kagaya K., Yamada T., Fukazawa Y. Mechanism for candidicidal activity in macrophages activated by recombinant gamma interferon. Infection and Immunity 1991; 59: 521–528
   PubMed Web of Science ®Google Scholar
• Wey S.B., Mori M., Pfaller M.A., Woolson R.F., Wenzel R.P. Hospital acquired candidemia: the attributable mortality and excess length of stay. Archives of Internal Medicine 1988; 148: 2642–2645
   PubMed Web of Science ®Google Scholar
• Wey S.B., Mori M., Pfaller M.A., Woolson R.F., Wenzel R.P. Risk factors for hospital acquired candidemia. A matched case-control study. Archives of Internal Medicine 1989; 149: 2349–2353
   PubMed Web of Science ®Google Scholar
• Wilson C.B. Immunologic basis for increased susceptibility of the neonate to infection. Journal of Pediatrics 1986; 108: 1–12
   PubMed Web of Science ®Google Scholar
• Wingard J.R., Merz W.G., Sandford G.R., Saral R., Burns W.H. Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice. Infection and Immunity 1980; 29: 808–813
   PubMed Web of Science ®Google Scholar
• Wysong D.R., Lyman C.A., Diamond R.D. Independence of neutrophil respiratory burst oxidant generation from the early cytosolic calcium response after stimulation with unopsonized Candida albicans hyphae. Infection and Immunity 1989; 57: 1499–1505
   PubMed Web of Science ®Google Scholar
• Yamamura M., Valdimarsson H. Participation of C3 in intracellular killing of Candida albicans. Scandinavian Journal of Immunology 1977; 6: 591–594
   PubMed Web of Science ®Google Scholar
• Zunino S.J., Hudig D. Interactions between human natural killer (NK) lymphocytes and yeast cells: human NK cells do not kill Candida albicans although C. albicans blocks NK lysis of K562 cells. Infection and Immunity 1988; 56: 546–569
   Web of Science ®Google Scholar